182 related articles for article (PubMed ID: 17308286)
1. Does chronic subthalamic nucleus stimulation in advanced Parkinson's disease cause invalidating cognitive and behavioural dysfunctions?
Speelman JD; Smeding HM; Schmand B
J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):221. PubMed ID: 17308286
[TBL] [Abstract][Full Text] [Related]
2. [Psychiatric and cognitive complications arising from subthalamic stimulation in Parkinson's disease].
Castro-García A; Sesar-Ignacio A; Ares-Pensado B; Relova-Quinteiro JL; Gelabert-González M; Rumbo RM; Noya-García M
Rev Neurol; 2006 Aug 16-31; 43(4):218-22. PubMed ID: 16883511
[TBL] [Abstract][Full Text] [Related]
3. [Deep brain stimulation in Parkinson's disease: overview on the pros and cons of an effective therapy].
Bötzel K; Dieterich M
Fortschr Neurol Psychiatr; 2011 Dec; 79(12):691. PubMed ID: 22161165
[No Abstract] [Full Text] [Related]
4. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
[TBL] [Abstract][Full Text] [Related]
5. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
[TBL] [Abstract][Full Text] [Related]
6. The psychiatric and neuropsychiatric symptoms after subthalamic stimulation for Parkinson's disease.
Mosley PE; Marsh R
J Neuropsychiatry Clin Neurosci; 2015; 27(1):19-26. PubMed ID: 25716484
[TBL] [Abstract][Full Text] [Related]
7. Mood and behavioural effects of subthalamic stimulation in Parkinson's disease.
Castrioto A; Lhommée E; Moro E; Krack P
Lancet Neurol; 2014 Mar; 13(3):287-305. PubMed ID: 24556007
[TBL] [Abstract][Full Text] [Related]
8. Preserved cognition after deep brain stimulation (DBS) in the subthalamic area for Parkinson's disease: a case report.
Cyron D; Funk M; Deletter MA; Scheufler K
Acta Neurochir (Wien); 2010 Dec; 152(12):2097-100. PubMed ID: 20676703
[TBL] [Abstract][Full Text] [Related]
9. Periodic hiccup in patients with subthalamic deep brain stimulation for Parkinson's disease.
Jochim A; Castrop F; Gempt J; Haslinger B
Parkinsonism Relat Disord; 2015 Sep; 21(9):1117-8. PubMed ID: 26216075
[No Abstract] [Full Text] [Related]
10. Acute Frequency-Dependent Hypomania Induced by Ventral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Case Report.
Scangos KW; Shahlaie K
Biol Psychiatry; 2017 Sep; 82(5):e39-e41. PubMed ID: 28017300
[No Abstract] [Full Text] [Related]
11. Transient executive dysfunction following STNDBS in Parkinson's disease.
Auclair-Ouellet N; Chantal S; Cantin L; Prud'homme M; Langlois M; Macoir J
Can J Neurol Sci; 2011 Mar; 38(2):360-3. PubMed ID: 21320849
[No Abstract] [Full Text] [Related]
12. Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
Fraraccio M; Ptito A; Sadikot A; Panisset M; Dagher A
Arch Clin Neuropsychol; 2008 Jul; 23(4):399-408. PubMed ID: 18394859
[TBL] [Abstract][Full Text] [Related]
13. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease.
Fritsche HM; Ganzer R; Schlaier J; Wieland WF; Brawanski A; Lange M
Mov Disord; 2009 Jul; 24(10):1553-4. PubMed ID: 19441136
[No Abstract] [Full Text] [Related]
14. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
[TBL] [Abstract][Full Text] [Related]
15. Decrease in blood cortisol corresponds to weight gain following deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
Růžička E; Nováková L; Jech R; Urgošík D; Růžička F; Haluzík M
Stereotact Funct Neurosurg; 2012; 90(6):410-1. PubMed ID: 23075541
[No Abstract] [Full Text] [Related]
16. Subthalamic nucleus stimulation in Parkinson's disease: the other side of the medallion.
Temel Y
Exp Neurol; 2008 Jun; 211(2):321-3. PubMed ID: 18410927
[No Abstract] [Full Text] [Related]
17. Reducing cognitive-motor declines associated with bilateral subthalamic deep brain stimulation through computational modelling in a Parkinson's disease patient.
Alberts JL; Hallahan K; Thota A; Noecker AM; Vitek JL; McIntyre CC
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1170-2. PubMed ID: 20802213
[No Abstract] [Full Text] [Related]
18. Subthalamic deep brain stimulation for advanced Parkinson's disease: all that glitters is not gold.
Linazasoro G
J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):827. PubMed ID: 12754372
[No Abstract] [Full Text] [Related]
19. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson's disease.
Witt K; Daniels C; Volkmann J
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S168-70. PubMed ID: 22166423
[TBL] [Abstract][Full Text] [Related]
20. "Persistent" hyperkinetic movements after deep brain stimulation of the subthalamic nucleus for Parkinson's disease.
Stathis PG; Smpiliris ME; Sakas DE
Clin Neurol Neurosurg; 2013 Aug; 115(8):1493-5. PubMed ID: 23266264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
